Investigating how small molecules can control immune system activity
Monitoring and Manipulating the Activity of the Immunoproteasome with Small Molecules
This study is looking at a special enzyme that helps control the immune system, and it's testing how small molecules can change its activity to improve treatments for autoimmune diseases, making sure the immune system works better against infections while calming down unwanted responses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10895002 on NIH RePORTER |
What this research studies
This research focuses on the immunoproteasome, a specialized enzyme that helps regulate the immune response by degrading proteins. By using small molecules to manipulate the activity of the immunoproteasome, the research aims to understand how this can affect the production of peptides that signal immune cells. This could potentially lead to new treatments for autoimmune diseases by reducing inappropriate immune responses while enhancing responses to infections. The approach involves both monitoring the activity of the immunoproteasome and testing how changes in its function can influence immune signaling.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with autoimmune diseases who may benefit from improved immune regulation.
Not a fit: Patients with non-autoimmune conditions or those who do not have an active immune response may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that better manage autoimmune diseases and improve immune responses to infections.
How similar studies have performed: Previous research has shown promise in manipulating immune responses through similar mechanisms, indicating potential for success in this area.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Trader, Darci J — University of California-Irvine
- Study coordinator: Trader, Darci J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.